Skip to main content
SpringerLink
Log in

Evolving Concepts and Challenges in Sepsis and MODS

...a brief history...from chaos to order...

  • Conference paper
Book cover Sepsis and Organ Dysfunction

  • 110 Accesses

Abstract

Sepsis is a life-threatening condition in patients admitted to critical care units. Sepsis consumes considerable healthcare resources in acute care hospitals. Considering the rapid evolution of knowledge,few studies on sepsis epidemiology are available [1, 2]; the sepsis-related mortality rate has persisted despite recent advances in understanding the complex pathophysiology of sepsis and significant improvements in the clinician’s ability to monitor and provide high technological function supports and management for critically ill patients in today’s intensive care unit (ICU) (Tables 1 and 2).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Salvo I, De Cian W, Musicco M, et al (1995) The Sepsis Study Group; The Italian sepsis study: preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 21: 5244–5249

    Article  Google Scholar 

  2. Rangel Frausto MS, Pittet D, Costigan M, et al (1995) The natural history of the systemic inflammatory response syndrome ( SIRS ). JAMA 273: 117–123

    Article  PubMed  CAS  Google Scholar 

  3. Opal SM, Fisher CJ Jr, Dhainaut JF, et al (1997) Confirmatory interleukin-1 receptor antagonist trial in severe sepsis. A phase III, randomised, double-blind, placebo-controlled, multicenter trial. Crit Care Med 25: 1115–1124

    Article  PubMed  CAS  Google Scholar 

  4. Bernard GR, Wheeler AP, Russell JA, et al (1997) The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med 336: 912–918

    Article  PubMed  CAS  Google Scholar 

  5. Centers for Disease Control (1990) Increase in national hospital discharge survey rates for septicaemia—United States, 1979–1987. JAMA 263: 937–938

    Article  Google Scholar 

  6. Kieft H, Hoepelman AI, Zhou W, et al (1993) The sepsis syndrome in a Dutch university hospital. Clinical observations. Arch Intern Med 153: 2241–2247

    Article  PubMed  CAS  Google Scholar 

  7. Bone RC, Balk RA, Cerra FB, et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee, American College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644–1655

    Article  PubMed  CAS  Google Scholar 

  8. Angus DC, Linde-Zwirble, Lidicker J, et al (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303–1310

    Article  PubMed  CAS  Google Scholar 

  9. Sprung CL, Bernard GR, Dellinger RP (2001) Guidelines for the management of severe sepsis and septic shock. Intensive Care Med 27 [Suppl]: S1 - S134

    Google Scholar 

  10. Sprung CL, Bernard GR, Dellinger RP (2001) Guidelines for the management of severe sepsis and septic shock. Introduction. Intensive Care Med 27 [Suppl 1]: Sl-S2

    Article  Google Scholar 

  11. Stedman’s Medical Dictionary (1995) 36th edn Williams and Wilkins, Baltimore

    Google Scholar 

  12. Pinsky MR, Vincent JL, Deviere J, et al (1993) Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 103: 565–575

    Article  PubMed  CAS  Google Scholar 

  13. American College of Chest Physicians/Society of Critical Care Medicine (1997) Consensus Conference defmitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients. Crit Care Med 25: 1789–1795

    Article  Google Scholar 

  14. Knaus WA, Harrell FE, Wagner DP (1994) Defining sepsis. JAMA 271: 1876–1878

    Article  Google Scholar 

  15. Vincent JL (1997) Dear SIRS, I’m sorry to say that I don’t like you…Crit Care Med 25: 372–374

    CAS  Google Scholar 

  16. Problem of sepsis. European Society of Intensive Care Medicine (1994) Intensive Care Med 20: 300–304

    Article  Google Scholar 

  17. Dobb GJ (1991) Multiple organ failure-words mean what I say they mean. Intensive Care World 8: 157–160

    Google Scholar 

  18. Barriere SL, Lowry SF (1995) An overview of mortality risk prediction in sepsis. Crit Care Med 23: 376–393.

    Article  PubMed  CAS  Google Scholar 

  19. Vincent JL, Moremùno R, Takala J, et al (1996) The SOFA ( Sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Intensive Care Med 22: 707–710

    Article  PubMed  CAS  Google Scholar 

  20. Vincent JL, De Mendonca A, Cantraine F, et al (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicentric, prospective study. Crit Care Med 26: 1793–1800

    Article  PubMed  CAS  Google Scholar 

  21. Baumgartner JD, Bula C, Vaney C, et al (1992) A novel score for predicting the mortality of septic shock patients. Crit Care Med 20: 953–960

    Article  PubMed  CAS  Google Scholar 

  22. Hebert PC, Drummond AJ, Singer J, et al (1993) A simple multiple system organ failure scoring system predicts mortality of patients who have sepsis syndrome. Chest 19: 137–144

    Google Scholar 

  23. Bernard GR (1998) Quantification of organ dysfunction: seeking standardization. Crit Care Med 26: 1767–1768

    Article  PubMed  CAS  Google Scholar 

  24. Knaus WA, Wagner DP, Draper EA, et al (1991) The APACHE III prognostic system. Risk prediction of hospital mortality in critically ill hospitalised adults. Chest 100: 1619–1636

    Article  PubMed  CAS  Google Scholar 

  25. Le Gall JR, Loirat P, Alperovitch A, et al (1984) A simplified acute physiology score of ICU patients. Crit Care Med 12: 975–977

    Article  PubMed  Google Scholar 

  26. Marshall JC, Cook DJ, Christou NV, et al (1995) Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 23: 1638–1652

    Article  PubMed  CAS  Google Scholar 

  27. Le Gall JR, Klar J, Lemeshow S, et al for the ICU scoring group (1996). The Logistic Organ Dysfunction System. A new way to assess organ dysfunction in the intensive care unit. JAMA 376: 802–810

    Google Scholar 

  28. Cressman DE, Greenbaum LE, DeAngelis RA, et al (1996) Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274: 1379–1383

    Article  PubMed  CAS  Google Scholar 

  29. Deutschman CS (1998) Acute-phase responses and SIRS/MODS: the good, the bad, and the nebulous. Crit Care Med 26: 1630–1631

    Article  PubMed  CAS  Google Scholar 

  30. Bone RC (1995) Sepsis and controlled trials: the odyssey continues. Crit Care Med 25: 1313–1315

    Article  Google Scholar 

  31. Dellinger RP (2001) Bad and good news in pathophysiology, prevention, and management of sepsis. In: Sepsis and organ dysfunction. Baue AE, Berlot G, Gullo A, Vincent JL (eds) Springer, Berlin Heidelberg New York

    Google Scholar 

  32. Bone RC (1996) Toward a theory regarding the pathogenesis of the inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med 24: 163–172

    Article  PubMed  CAS  Google Scholar 

  33. Abraham E (1999) Why immunomodulatory therapies have not worked in sepsis. Intensive Care Med 25: 556–566

    Article  PubMed  CAS  Google Scholar 

  34. Cohen J (1999) The “failure” of clinical trials in sepsis. Curr Opin Crit Care 339–340

    Google Scholar 

  35. Marshall JC (ed) (1999) Sepsis, vol. 3. Kluwer

    Google Scholar 

  36. Keane MP, Strieter RM (2000) Chemokine signalling in inflammation. Crit Care Med 28 [Suppl]: N13 - N26

    Article  PubMed  CAS  Google Scholar 

  37. Yaffe MB, Fink MP (2000) Cellular signalling in critical care. Putting the pieces together. Crit Care Med 28 [Suppl]: N1 - N2

    Article  PubMed  CAS  Google Scholar 

  38. Hotchkiss RS, Swanson PE, Freeman BD, et al (1999) Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 27: 1230–1251

    Article  PubMed  CAS  Google Scholar 

  39. Abraham E, Matthay MA, Dinarello CA, et al (2000) Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit Care Med 28: 232–235

    Article  PubMed  CAS  Google Scholar 

  40. Le-Barillec K, Henneke P, Golenbock DT (2000) Toll receptors: guardians of the immune system and effectors of septic shock. Advances in sepsis. ReMEDICA, pp 23–30

    Google Scholar 

  41. Beutler B, Poltorak A (2001) Sepsis and evolution of the innate immune response. Crit Care Med 29: S2 - S7

    Article  PubMed  CAS  Google Scholar 

  42. Ulevitch RJ (2001) New therapeutic targets revealed through investigations of innate immunity. Crit Care Med 29: S8 - S12

    Article  PubMed  CAS  Google Scholar 

  43. Carlet J (2001) Immunological therapy in sepsis: currently available. Intensive Care Med 27: 593 - S103

    Article  Google Scholar 

  44. Dhainaut JF, Giroir B, Opal S (2001) Introduction to the second Margaux Conference on Critical Illness. Sepsis: interface between inflammation, coagulation, and the endothelium. Crit Care Med 29: S1

    Article  Google Scholar 

  45. Fourrier F, Chopin C, Huart JJ, et al (1993) Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 104: 882–888

    Article  PubMed  CAS  Google Scholar 

  46. Baudo F, Caimi TM, Cataldo F de, et al (1998) Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or post-surgical complications: a controlled double-blind, randomized, multicenter study. Intensive Care Med 24: 336–342

    Article  PubMed  CAS  Google Scholar 

  47. Eisele B, Lamy M, Thijs LG, et al (1998) Anti-thrombin III in patients with severe sepsis: a randomised, placebo-controlled, double blind. Multicenter trial plus a meta-analysis on all randomised placebo-controlled, double-blind trials with antithrombin III in severe sepsis. Intensive Care Med 24: 663–672

    Article  PubMed  CAS  Google Scholar 

  48. Riess H (2000) Antithrombin in severe sepsis. “New” indication of an “old” drug. Intensive Care Med 26: 657–665

    Article  PubMed  CAS  Google Scholar 

  49. Bernard GR, Vincent JL, Laterre PF, et al (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699–709

    Article  PubMed  CAS  Google Scholar 

  50. Baue AE (1999) Introduction in sepsis and organ dysfunction. In: Baue AE, Berlot G, Gullo A, Vincent JL (eds) Sepsis and organ dysfunction, Springer Verlag Italia, Milan 13–19

    Google Scholar 

  51. Baue AE (1998) The complexities of sepsis and organ dysfunction. In: Baue AE, Berlot G, Gullo A, Vincent JL (eds) Sepsis and organ dysfunction, Springer Verlag Italia, Milan 23–31

    Google Scholar 

  52. Baue AE (2001) Sepsis and organ dysfunction: an overview of the new science and new biology. In: Baue AE, Berlot G, Gullo A, Vincent Jl (eds) Sepsis and organ dysfunction, Springer Verlag Italia, Milan 123–132

    Google Scholar 

  53. Bion JF, Brun-Buisson C (2000) Introduction — infection and critical illness: genetic and environmental aspects of susceptibility and resistance. Intensive Care Med 26: S1 - S2

    Article  PubMed  Google Scholar 

Download references

Authors
  1. A. Gullo
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Surgery, S. Louis University, School of Medicine, Fishers Island, New York, USA

    A. E. Baue M.D. (Emeritus Professor) (Emeritus Professor)

  2. Department of Clinical Sciences, Section of Anaesthesia, Intensive Care and Pain Clinic, Trieste University Medical School, Trieste, Italy

    G. Berlot M.D.  & A. Gullo M.D.  & 

  3. Department of Intensive Care, Erasme University Hospital, Free University of Brussels, Brussels, Belgium

    J.-L. Vincent M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Italia, Milano

About this paper

Cite this paper

Gullo, A. (2002). Evolving Concepts and Challenges in Sepsis and MODS. In: Baue, A.E., Berlot, G., Gullo, A., Vincent, JL. (eds) Sepsis and Organ Dysfunction. Springer, Milano. https://doi.org/10.1007/978-88-470-2213-3_17

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2213-3_17

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0178-7

  • Online ISBN: 978-88-470-2213-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation